top of page

A Celonic success story
https://www.celonic.com/general/celonic-launches-the-new-gs-chovolution-system-based-on-revvitys-chosourcetm-expression-platform/
Rachel Ougier Simonin
Mar 19, 20241 min read


Take aways - building your Leadership Branding
Thank you to Shivangi Walke for sharing the key highlights of her Listen & Learn in February 2024!
Rachel Ougier Simonin
Mar 13, 20241 min read
US pricing: parity between biologics and small molecules
https://www.biospace.com/article/stakeholders-hope-bill-will-create-ira-drug-negotiation-parity-between-biologics-and-small-molecules-/
Rachel Ougier Simonin
Mar 7, 20241 min read
Biotech IPO venture funding outlook for 2024
https://www.biopharmadive.com/news/biotech-ipo-venture-funding-outlook-2024/709084/?utm_source=Sailthru&utm_medium=email&utm_campaign=Iss...
Rachel Ougier Simonin
Mar 6, 20241 min read
Insights for Healthcare Innovators
What are the first health care applications of quantum computing? Listen to the great conversation with Frederik Floether on the Care...
Rachel Ougier Simonin
Mar 5, 20241 min read
Is 2024 the year of Lean fractional C-Suites?
https://www.biospace.com/article/is-2024-the-year-of-lean-fractional-c-suites-/
Rachel Ougier Simonin
Mar 5, 20241 min read
US and EU Healthcare market update (from Back Bay)
https://us4.campaign-archive.com/?e=%5BUNIQID%5D&u=e2b9105c5aab455a12293b45e&id=51a2377265
Rachel Ougier Simonin
Mar 4, 20241 min read
Judge denies AstraZeneca’s lawsuit against Medicare negotiation
https://thehill.com/policy/healthcare/4501552-judge-denies-astrazenecas-lawsuit-against-medicare-negotiation/
Rachel Ougier Simonin
Mar 2, 20241 min read
2024 will be a buyers’ market in Biopharma
https://www.biospace.com/article/opinion-2024-will-be-a-buyers-market-in-biopharma-it-already-is/
Rachel Ougier Simonin
Feb 29, 20241 min read
Getting genes therapies into the fast lane
With a rich pipeline of hundreds of candidate therapeutics in all phases of clinical development and evaluation, across all platform...
Rachel Ougier Simonin
Feb 26, 20241 min read
Generative AI in the Pharma Industry (McKinsey)
https://www.mckinsey.com/industries/life-sciences/our-insights/generative-ai-in-the-pharmaceutical-industry-moving-from-hype-to-reality?s...
Rachel Ougier Simonin
Feb 8, 20241 min read
Revenue loss due to patent expirations
https://www.cnbc.com/2024/01/28/big-pharma-merck-bristol-myers-jj-prepare-to-lose-revenue.html
Rachel Ougier Simonin
Feb 5, 20241 min read
Swiss Ventures Capital report 2024
https://www.startupticker.ch/en/swiss-venture-capital-report
Rachel Ougier Simonin
Feb 2, 20241 min read
Women’s health gap & Economics - McKinsey report
https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-a-1-trillion-dollar-opportunity-to-improve-lives-and-economies
Rachel Ougier Simonin
Feb 1, 20241 min read
IPO forecasts - 2024
https://www.fiercebiotech.com/biotech/cgs-and-arrivents-oversized-ipos-bode-well-2024-after-dreary-year
Rachel Ougier Simonin
Jan 29, 20241 min read
5 questions Pharma faces in 2024
https://www.biopharmadive.com/news/pharma-outlook-2024-obesity-cancer-ira-alzheimers/704138/
Rachel Ougier Simonin
Jan 19, 20241 min read
Ventures Healthcare report 2023
https://www.hsbcinnovationbanking.com/en-gb/venture-healthcare-report
Rachel Ougier Simonin
Jan 18, 20241 min read
1 visual about Healthcare in Basel
https://invest.baselarea.swiss//wp-content/uploads/sites/3/2023/05/Life-Science-infographic_web-2.jpg.webp
Rachel Ougier Simonin
Jan 17, 20241 min read
Basel life sciences sector is the most productive in the world
https://baselarea.swiss/blog-post/basel-life-sciences-sector-is-the-most-productive-in-the-world/
Rachel Ougier Simonin
Jan 17, 20241 min read
BASEL IS “PROBABLY THE MOST PRODUCTIVE LIFE SCIENCES LOCATION IN THE WORLD”
https://www.s-ge.com/en/article/news/20203-life-science-most-productive-life-sciences-location?ct
Rachel Ougier Simonin
Jan 17, 20241 min read
bottom of page